MENU
CARM
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Carisma Therapeutics (CARM) Ownership - Who owns Carisma Therapeutics?

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma’s proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
20.92K
P/E Ratio
0.00
Total Cash
2.78M
Projected Growth
N/A
Total Debt
762K
Revenue
52.63M
Risk (Beta)
1.58
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
N/A
Revenue/Share
1.26 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details